Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linda Gowing

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Addiction (Abingdon, England)|May 2, 2015
Identifying corrections-is there a better way?Linda Gowing
Journal of Addiction|February 13, 2020
Is Long-Term Benzodiazepine Use a Risk Factor for Cognitive Decline? Results of a Systematic ReviewDanilo Nader, Linda Gowing
BMJ (Clinical Research Ed.)|May 17, 2012
Maintenance drugs to treat opioid dependenceMichael Farrell, Alex Wodak, Linda Gowing
The Cochrane Database of Systematic Reviews|April 28, 2017
Supervised dosing with a long-acting opioid medication in the management of opioid dependenceRosella Saulle, Simona Vecchi, Linda Gowing
The Cochrane Database of Systematic Reviews|October 13, 2009
Opioid antagonists with minimal sedation for opioid withdrawalLinda Gowing, Robert Ali, Jason M White
The Cochrane Database of Systematic Reviews|January 22, 2010
Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawalLinda Gowing, Robert Ali, Jason M White
The Cochrane Database of Systematic Reviews|May 30, 2017
Opioid antagonists with minimal sedation for opioid withdrawalLinda Gowing, Robert Ali, Jason M White
The Cochrane Database of Systematic Reviews|July 10, 2009
Buprenorphine for the management of opioid withdrawalLinda Gowing, Robert Ali, Jason M White
The Cochrane Database of Systematic Reviews|December 18, 2014
Pharmacotherapies for cannabis dependenceKushani Marshall, Linda Gowing, Robert Ali, et al.
Handbook of Experimental Pharmacology|August 4, 2019
Pharmacotherapies for Cannabis Use Disorders: Clinical Challenges and Promising Therapeutic AgentsSuzanne Nielsen, Pamela Sabioni, Linda Gowing, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Addiction (Abingdon, England)|May 2, 2015
Identifying corrections-is there a better way?Linda Gowing
Journal of Addiction|February 13, 2020
Is Long-Term Benzodiazepine Use a Risk Factor for Cognitive Decline? Results of a Systematic ReviewDanilo Nader, Linda Gowing
BMJ (Clinical Research Ed.)|May 17, 2012
Maintenance drugs to treat opioid dependenceMichael Farrell, Alex Wodak, Linda Gowing
The Cochrane Database of Systematic Reviews|April 28, 2017
Supervised dosing with a long-acting opioid medication in the management of opioid dependenceRosella Saulle, Simona Vecchi, Linda Gowing
The Cochrane Database of Systematic Reviews|October 13, 2009
Opioid antagonists with minimal sedation for opioid withdrawalLinda Gowing, Robert Ali, Jason M White
The Cochrane Database of Systematic Reviews|January 22, 2010
Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawalLinda Gowing, Robert Ali, Jason M White
The Cochrane Database of Systematic Reviews|May 30, 2017
Opioid antagonists with minimal sedation for opioid withdrawalLinda Gowing, Robert Ali, Jason M White
The Cochrane Database of Systematic Reviews|July 10, 2009
Buprenorphine for the management of opioid withdrawalLinda Gowing, Robert Ali, Jason M White
The Cochrane Database of Systematic Reviews|December 18, 2014
Pharmacotherapies for cannabis dependenceKushani Marshall, Linda Gowing, Robert Ali, et al.
Handbook of Experimental Pharmacology|August 4, 2019
Pharmacotherapies for Cannabis Use Disorders: Clinical Challenges and Promising Therapeutic AgentsSuzanne Nielsen, Pamela Sabioni, Linda Gowing, et al.
Pageof 3